cysteine has been researched along with docetaxel anhydrous in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azrak, RG; Foster, BA; Frank, CL; Li, F; Ling, X; Rustum, YM; Slocum, HK | 1 |
| Chiu, YT; Chua, CW; Howard, EW; Lee, DT; Wang, X; Wong, YC | 1 |
| Barnetson, R; Doyle, B; Fleming, J; Kozielski, F; Leung, HY; Robson, CN; Singh, BL; Stockley, J; Wiltshire, C | 1 |
| Ding, ST; Fujii, N; Inoue, T; Kobayashi, T; Lv, JJ; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S; Saito, R; Xing, ND | 1 |
| Choi, YH; Kim, YG; Lee, MG; Yoon, I | 1 |
| Chao, Y; Fang, G; Gou, J; Tang, B; Tang, X; Xu, H; Zhang, Y | 1 |
| Bertrand, N; Choi, WI; Farokhzad, OC; MacLean, JL; Mulvale, M; Shah, V; Shi, J; Wu, J; Xu, X; Yameen, B; Zhao, L | 1 |
| Kong, CC; Liu, XD; Song, CY; Tian, X | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and docetaxel anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for cysteine and docetaxel anhydrous
| Article | Year |
|---|---|
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; BCG Vaccine; Cefotetan; Cephamycins; Contrast Media; Cysteine; Dapsone; Diltiazem; Dipyrone; Docetaxel; Drug Eruptions; Echinacea; Enoxaparin; Female; Fructose; Glucans; Glucose; Gold Sodium Thiomalate; Humans; Ibuprofen; Icodextrin; Ioxaglic Acid; Male; Middle Aged; Minocycline; Paclitaxel; Pregnancy; Solvents; Taxoids; Topiramate; Triamcinolone; Trichloroethylene | 2001 |
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Enzyme Activation; Inhibitor of Apoptosis Proteins; Male; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Survivin; Taxoids | 2006 |
Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cadherins; Cell Division; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Flow Cytometry; G2 Phase; Garlic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Transplantation, Heterologous; Tumor Stem Cell Assay; Up-Regulation | 2008 |
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cysteine; Docetaxel; Drug Screening Assays, Antitumor; Humans; Kinesins; Male; Propidium; Prostatic Neoplasms; Taxoids; Up-Regulation | 2010 |
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Cysteine; Docetaxel; Drug Resistance, Neoplasm; Humans; Kinesins; Male; Mice; Mice, Nude; Prostatic Neoplasms; Protein Array Analysis; Taxoids; Trityl Compounds; Xenograft Model Antitumor Assays | 2011 |
Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition.
Topics: Administration, Oral; Animals; Biological Transport; Blood Chemical Analysis; Blood Proteins; Caco-2 Cells; Cysteine; Docetaxel; Dose-Response Relationship, Drug; Duodenum; Energy Intake; Humans; Injections, Intravenous; Kidney; Kinetics; Liver; Male; Microsomes, Liver; Organ Size; Protein Binding; Protein-Energy Malnutrition; Rats; Rats, Sprague-Dawley; Rhodamine 123; Taxoids; Time Factors; Weight Gain | 2012 |
Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
Topics: Administration, Oral; Animals; Area Under Curve; Cysteine; Docetaxel; Drug Carriers; Drug Delivery Systems; Intestinal Absorption; Lipids; Male; Nanostructures; Particle Size; Permeability; Photoelectron Spectroscopy; Rats; Rats, Sprague-Dawley; Taxoids | 2015 |
Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cysteine; Disulfides; Docetaxel; Drug Carriers; Fluorescence Resonance Energy Transfer; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Neoplasms; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Polymers; Taxoids; Theranostic Nanomedicine | 2015 |
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
Topics: Antioxidants; Apoptosis; Bufanolides; Caspase 3; Cell Line; Cell Line, Tumor; Cysteine; Docetaxel; Doxorubicin; Fluorescein-5-isothiocyanate; Humans; Necroptosis; Propidium; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2022 |